BRAINTREE, Mass., July 12, 2025 /PRNewswire/ -- The Vertex Companies LLC (Vertex), a global consulting firm in business, AEC and legal...
13 hours ago

Vertex Pharmaceuticals' investigational, off-the-shelf cell therapy zimislecel helps control blood sugar levels in patients with type 1 diabetes...
3 weeks ago

Vertex Pharmaceuticals Incorporated remains a top Buy with a strong cystic fibrosis franchise, innovative pipeline, and cell therapies.
3 days ago

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its second quarter 2025 financial results on Monday, August 4, 2025 after the...
4 days ago

Vertex, Inc. (NASDAQ: VERX), a provider of tax technology solutions, has become a focal point for investors debating whether its valuation...
1 day ago

PGIM Jennison Health Sciences Fund released its first quarter 2025 investor letter. A copy of the letter can be downloaded here.
4 days ago

Vertex Pharmaceuticals' cystic fibrosis (CF) therapy Alyftrek (deutivacaftor/tezacaftor/vanzacaftor) has been approved by the European...
3 days ago

Developers are actively working to bring AI agents to market, but a significant hurdle has been the lack of memory. Without the ability to...
2 days ago

Sodium channel blockers for pain: New opportunities after Vertex's 'watershed' moment. The success of Vertex's opioid alternative Journavx could...
2 weeks ago

We are the most innovative, make the best decisions for patients and attract the highest caliber of talent because our workforce represents the best and...
3 months ago